Abbott Reports First-Quarter 2022 Results
(Source: Abbott.com)
Source: Abbott.com - April 20, 2022 Category: Pharmaceuticals Source Type: news
Abbott Receives FDA Approval for Aveir ™ VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms
(Source: Abbott.com)
Source: Abbott.com - April 4, 2022 Category: Pharmaceuticals Source Type: news
Abbott and LISC Team Up to Address Diversity and Equity Gaps in the Healthcare Industry Supply Chain
(Source: Abbott.com)
Source: Abbott.com - March 30, 2022 Category: Pharmaceuticals Source Type: news
Abbott Hosts Conference Call for First-Quarter Earnings
(Source: Abbott.com)
Source: Abbott.com - March 28, 2022 Category: Pharmaceuticals Source Type: news
Abbott's FreeStyle ® Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin
(Source: Abbott.com)
Source: Abbott.com - March 24, 2022 Category: Pharmaceuticals Source Type: news
Military Members, Families and Retirees Get Simplified Access to Abbott ’s FreeStyle® Libre 2 system Through TRICARE®
- TRICARE members now have faster, easier, and more convenient access to continuous glucose monitoring (Source: Abbott.com)
Source: Abbott.com - March 1, 2022 Category: Pharmaceuticals Source Type: news
Abbott's CardioMEMS ™ HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure
- New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS ™ HF System, a small implantable sensor that can flag early warning signs of worsening heart failure (Source: Abbott.com)
Source: Abbott.com - February 21, 2022 Category: Pharmaceuticals Source Type: news
Abbott Declares 393rd Consecutive Quarterly Dividend
(Source: Abbott.com)
Source: Abbott.com - February 18, 2022 Category: Pharmaceuticals Source Type: news
Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant
Recall is isolated to powder formulas, including Similac ®, Alimentum ® and EleCare®, manufactured at the Sturgis, Mich., plant (Source: Abbott.com)
Source: Abbott.com - February 17, 2022 Category: Pharmaceuticals Source Type: news
Abbott Announces World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial
- Abbott's investigational Aveir ™ DR dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart (Source: Abbott.com)
Source: Abbott.com - February 7, 2022 Category: Pharmaceuticals Source Type: news
UnitedHealthcare Extends Coverage to Abbott ’s Unique Neurostimulation Therapy for Nerve Pain
- Abbott ’s Proclaim™ dorsal root ganglion (DRG) neurostimulation system is the only FDA-approved DRG technology for the treatment of CRPS I and causalgia of the lower extremitiesi (Source: Abbott.com)
Source: Abbott.com - February 3, 2022 Category: Pharmaceuticals Source Type: news
Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast
- Fourth-quarter sales growth of 7.2 percent; organic sales growth of 7.7 percent (Source: Abbott.com)
Source: Abbott.com - January 26, 2022 Category: Pharmaceuticals Source Type: news
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
- EnSite ™ X EP System with EnSite Omnipolar Technology (OT) provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise (Source: Abbott.com)
Source: Abbott.com - January 12, 2022 Category: Pharmaceuticals Source Type: news
Abbott Announces Future of Biowearables at Consumer Electronics Show
- The company announced it's developing a new category of consumer biowearables called Lingo, which is being designed to track key signals in the body - such as glucose, ketones, and lactate - to help people better understand their general health and take action (Source: Abbott.com)
Source: Abbott.com - January 6, 2022 Category: Pharmaceuticals Source Type: news
Abbott Hosts Conference Call for Fourth-Quarter Earnings
(Source: Abbott.com)
Source: Abbott.com - January 4, 2022 Category: Pharmaceuticals Source Type: news
